M&A Deal Summary |
|
---|---|
Date | 2008-09-03 |
Target | Neurotech Pharmaceuticals |
Sector | Media |
Buyer(s) | Triginta Capital |
Deal Type | Buyout (LBO, MBO, MBI) |
SEARCH BY
Try For Free 7-Day Free Trial
Category | Private Equity Firm |
---|---|
Founded | 2000 |
Size | Middle-Market |
Type | Sector Agnostic |
Triginta Capital is a private equity firm focused on making control investments in small and medium-sized companies in German speaking Europe. Triginta generally seeks businesses valued up to €20 million in the manufacturing and services sectors (B2B and B2C). In addition to investing in companies, Triginta also acquires entire portfolios of investments. Triginta Capital was formed in 2000 and is based in Dusseldorf.
DEAL STATS | # |
---|---|
Overall | 11 of 11 |
Sector (Media) | 1 of 1 |
Type (Buyout (LBO, MBO, MBI)) | 8 of 8 |
State (Rhode Island) | 1 of 1 |
Country (United States) | 1 of 1 |
Year (2008) | 1 of 1 |
DATE | TARGET | DEAL TYPE | VALUE |
---|---|---|---|
2008-01-01 |
Chiracon
Luckenwalde, Germany Development, production and distribution of chiral intermediates. |
Sell | - |
DATE | TARGET | DEAL TYPE | VALUE |
---|---|---|---|
2009-02-26 |
COR pumps + compressors AG
Stuttgart, Germany COR pumps + compressors AG (HTB) innovative technology to develop pumps and compressors. |
Sell | - |